BioSpace News Archive

Albireo Pharma, Inc., a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced that it has commenced a proposed underwritten public offering of 3,000,000 shares of its common stock.

Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer, today announced that it intends to offer and sell, subject to market conditions, 10,000,000 shares of its common stock in an underwritten public offering

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Morgan Stanley 18th Annual Global Healthcare Conference at 1:30 p.m. ET on Monday, September 14, 2020.

entrinsic bioscience, a company pioneering a next generation protein modulation technology, announced the appointment of Mario Wanderley as Chief Financial Officer.

Jazz Pharmaceuticals plc announced that the company will webcast its corporate presentations at the following virtual investor conferences:

TransEnterix, Inc. announced that Anthony Fernando, President and Chief Executive Officer and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will present at the H. C. Wainwright 22nd Annual Global Investment Conference.

GlycoMimetics, Inc. announced that Chief Executive Officer Rachel King will present at the upcoming H.C. Wainwright & Co 22nd Annual Global Investment Virtual Conference taking place September 14-16, 2020.

Exelixis, Inc. announced that members of the company’s management team will participate in fireside chats at the following virtual investor conferences in September:.

Parkinson’s Disease R&D Day to be hosted by Gavin Corcoran, MD, Chief R&D Officer, on October 30th, 2020, with leading movement disorder specialists

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed as XIAFLEX ® in North America , today announced that Joseph Truitt , Chief Executive Officer, will present at the H